Jump to content

Parabon NanoLabs

From Alfawiki
Adapted from the English Wikipedia article Parabon NanoLabs, available under CC BY-SA 4.0Updated 26 July 2025
Parabon NanoLabs, Inc.
Company typePrivate
IndustryNanopharmaceuticals, forensic DNA phenotyping, genetic genealogy
Founded2008
FounderSteven Armentrout, Michael Norton, Christopher Dwyer
Headquarters
Reston, Virginia
,
United States
Key people
Steven Armentrout (CEO and President as of 2018)
ProductsinSēquio Design Studio, Snapshot, Keystone
ParentParabon Computation

Parabon NanoLabs, Inc. is a U.S.-based firm located in Reston, Virginia that specializes in nanopharmaceutical development and provides DNA phenotyping solutions tailored for law enforcement agencies.

History

Established in 2008 by entrepreneurs Steven Armentrout, Michael Norton, and Christopher Dwyer, Parabon NanoLabs functions as a division of Parabon Computation, a company focused on computational software. As of 2018, Steven Armentrout held the positions of CEO and President. The organization concentrates on creating cancer therapies and synthetic vaccines utilizing advancements in nanotechnology and DNA phenotyping.

inSēquio Design Studio

Parabon created the inSēquio Design Studio software in partnership with the Edgewood Chemical Biological Center, United States Army Research Office, and the National Science Foundation through the Federal Small Business Innovation Research initiative. This CAD tool facilitates the nanoengineering of DNA constructs and has played a key role in developing synthetic vaccines.

Snapshot

Snapshot is a DNA phenotyping service developed by Parabon NanoLabs that produces composite facial images derived from genetic material. The proprietary algorithms used to generate these images have been criticized for their lack of transparency and absence of peer-reviewed validation, eliciting concern among forensic specialists and civil rights advocates. While trait predictions such as hair and eye color are generally considered dependable, the accuracy of facial structure forecasts remains limited.

Despite these concerns, Snapshot has proven valuable in practical law enforcement applications, notably assisting investigators in North Carolina to identify a suspect involved in a 2012 double homicide. Changes to privacy policies affecting genetic genealogy platforms like GEDmatch could increase dependence on DNA phenotyping technologies. Competitors including Illumina, Inc. and Identitas AG offer comparable services. The U.S. Department of Defense invested about $2 million toward Snapshot’s advancement.

Keystone

Parabon NanoLabs was awarded a two-year contract by the United States Department of Defense to develop 'Keystone,' a software platform designed for forensic DNA analysis.

Genetic genealogy

In May 2018, Parabon appointed genealogist CeCe Moore to lead its genetic genealogy division, which initially comprised three genealogists. Working alongside U.S. law enforcement agencies, Parabon uploaded crime scene DNA profiles to GEDmatch to assist in suspect identification.

By November 2018, Parabon was engaged in approximately 200 cases with a lead generation success rate of 55%; by May 2019, the company reported resolving cold cases at an average pace of one per week. However, GEDmatch’s May 2019 update requiring users to opt-in for law enforcement access introduced obstacles for Parabon's investigative work.

As of November 2019, Parabon had initiated around 300 DNA searches and successfully solved close to 100 cases, although arrests were still pending in several instances. By May 2020, the company had contributed to nearly 500 cases with 109 suspect identifications.

In December 2019, GEDmatch was acquired by Verogen, a forensic DNA firm whose CEO Brett Williams pledged to improve data security measures and oppose police search warrants.

By mid-2020, facing restricted access to GEDmatch, Parabon increased its utilization of Family Tree DNA through collaborations with partner law enforcement agencies. Family Tree DNA employs an opt-out policy for U.S. users and retains its own genetic genealogy expert, Barbara Rae-Venter, renowned for her role in solving the Golden State Killer case.

On May 26, 2020, ABC debuted The Genetic Detective, featuring Moore and her team from Parabon, showcasing their work in genetic genealogy investigations.

This progression highlights Parabon’s growing influence within the forensic genetic genealogy sector and its strategic leadership role.

Case outcomes: Pending trial

The cases listed below pertain to individuals apprehended in connection with various crimes. Each suspect is considered innocent until legally proven otherwise. Convictions are denoted with a green highlight.


Case outcomes: Admissions and pleas of guilt

The cases listed below involve individuals who confessed to their crimes and received sentences without undergoing a formal trial.

Case outcomes: Dismissals

The cases below ended with defendants being freed or found not guilty due to various reasons including dropped charges or expiration of statute limitations.


Case outcomes: Confirmation of deceased principal suspects

In these instances, the perpetrator was conclusively identified; however, they passed away prior to any legal proceedings. Although suspect identification was highly precise, prosecutions could not proceed, leaving the cases unresolved.

... (Table continues with similar condensed entries for other suspects) ...

Case outcomes: Resolving identities of John and Jane Does

Unidentified human remains are commonly assigned the names Jane Doe or John Doe. Establishing the identities of these individuals is vital in homicide inquiries, although not every case involves criminal activity.


External links